15.2000.65% ( -0.100 )
Delay Closed: Nov 16, 16:08:00Overview
LUZHU BIOTECH-B (2480)
Beijing Luzhu Biotechnology Co., Ltd., a biotechnology company, develops human vaccines and therapeutic biologics to prevent and control infectious diseases, an...
- Open
- 15.200
- High
- 15.200
- Low
- 15.200
- Prev. Close
- 15.300
- Volume
- 200
- Turnover
- 3.04K
- Avg Price
- 15.200
- Bid/Ask Ratio
- -100.00%
- Amplitude
- 0.00%
- 52wk High
- 25.980
- Volume Ratio
- 0.00
- Turnover Ratio
- 0.00%
- 52wk Low
- 12.000
- HK Mkt Cap
- 3.02B
- Market CapHKD
- 3.02B
- P/ETTM
- Loss
- P/EDynamic
- Loss
- P/EStatic
- --
- EPSTTM
- -0.778
- EPSDynamic
- -0.713
- EPSStatic
- --
- BVPS
- 3.46
- P/B
- 4.39
- HK Shares
- 198.91M
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- 198.91M
- Min lot size
- 200
- Currency
- HKD
LUZHU BIOTECH-B Analyst Rating
View moreForecast & Rating
Apr 27, 2026Price forecast
HK$30.93103.48%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
- Strong buy
- 1
- Buy
- 0
- Hold
- 0
- Sell
- 0
- Strong sell
- 0
News
Tip Ranks · Beijing Luzhu Clarifies Limits on Share Awards and Equity-Linked Deals in 2025 Report
Simplywall · Asian Growth Stocks With High Insider Ownership
Tip Ranks · Beijing Luzhu Biotechnology Publishes Unaudited Interim Results for First Half of 2026
PUBT · Beijing Luzhu Biotech FY26 H1 net loss narrows 20.6% to RMB 61.62 million
PUBT · Beijing Energy International schedules board meeting to review interim results, consider dividend
Tip Ranks · Luzhu Biotech’s Herpes Zoster Vaccine LZ901 Shows Strong Phase III Results in China
